Our Philadelphia Heart Attack Lawyers / Heart Damage Attorneys offer representation to clients who suffered heart attacks or other heart damage / injury due to defective drugs and medical devices. Heart injury or damage, including that sustained by a heart attack, can be a life-changing (catastrophic) injury with serious and lasting consequences.
Damages sustained in these cases can include:
- costs of permanent medical care and prescriptions
- multiple surgeries
- long-term care, rehabilitation, and therapy
- restricted mobility
- loss of wages / employment and earning capacity
Heart Injury / Damage and Heart Attack Caused by Defective Drugs and Medical Devices
Our Philadelphia Heart Attack Lawyers / Heart Damage Attorneys bring legal actions against makers of defective drugs and medical devices that result in heart injury or damage. Some of the many dangerous medications (drugs) and medical devices that may cause heart damage / injury include:
- IVC Blood Clot Filters
Philadelphia Heart Attack Lawyers / Heart Damage Attorneys file lawsuits against manufacturers of defective medical devices that cause heart damage / injuries. IVC Blood Clot Filters are metal medical devices that surgeons insert in the inferior vena cava (IVC) vein of someone at risk of pulmonary embolisms (blood clots in the lungs).
Intact IVC Filters or pieces of broken IVC Filters can travel to patients’ hearts, causing serious heart damage / injuries, including:
- right atrium wall perforation (puncturing)
- cardiac tamponade (life-threatening injury caused by penetration of the pericardium by broken IVC Filters)
- other blood flow problems
- heart attack
The FDA reported over 900 complaints of lung and heart injuries from IVC Filters in 2010, alone. See Philadelphia Blood Clot IVC Filter Injury Lawyers for more information about IVC Filter injuries and IVC Filter lawsuits.
Proton Pump Inhibitor (PPI) use is associated with heart damage / injury that can lead to heart attack. PPIs (heartburn and GERD medications) that may cause this dangerous heart injury / side effect include:
A 2015 study (published in PLOS One) showed an association between PPI use and a 1.16-fold increase in heart attack risk.
For more information about PPI risks and lawsuits, see:
Users of fluoroquinolone antibiotics Avelox, Cipro, and Levaquin are at increased risk of serious heart injury / damage and heart attack. Avelox, Cipro, and Levaquin use is associated with:
- dangerous and irreversible aortic bulges (aortic aneurysms)
- dangerous and irreversible aortic tears (aortic dissections), and
- heart attack that can result from these serious heart injuries
The November 2015 issue of JAMA Internal Medicine published a study linking use of Avelox, Cipro, Levaquin, and other fluoroquinolone antibiotics for as little as 60 days with a doubled risk of aortic aneurysms.
For more information about injuries caused by fluoroquinolone antibiotics and Avelox, Cipro, and Levaquin lawsuits, see:
Actos is a type-2 diabetes drug associated with congestive heart failure. The FDA mandated a black box warning on Actos packaging, in 2011, stating that Actos users have an increased risk of congestive heart failure. FDA black box warnings call attention to drug risks that are serious or life-threatening.
See Philadelphia Actos Drug Injury Lawyers for more information about Actos side effects and lawsuits.
GranuFlo is a chemical product that healthcare providers use in dialysis (kidney failure) treatments. GranuFlo is associated with serious and life-threatening heart injury / damage, including:
- cardiac arrhythmia
- cardiac arrest
In 2011, Fresenius, the manufacturer of GranuFlo, acknowledged that:
- GranuFlo and a similar product were linked to 914 incidents of cardiac arrest
- Fresenius’s own medical staff had determined that users of GranuFlo had a six-fold increased risk of cardiac arrest
See Philadelphia GranuFlo Drug Injury Lawyers for more information about GranuFlo dangers and lawsuits.
The type-2 diabetes drug, Onglyza, is associated with an increased risk of heart failure. The FDA required additions to Onglyza warning labels, in 2016, stating that:
- Onglyza users have an increased risk of heart failure
- Onglyza users with kidney or heart disease are at an even greater risk of heart failure from Onglyza.
See Philadelphia Onglyza Drug Injury Lawyers for more information about Onglyza side effects and lawsuits.
Contact our Philadelphia Heart Attack Lawyers / Heart Damage Attorneys
If you suffered heart damage or a heart attack due to a defective drug or medical device, our Philadelphia Heart Attack Lawyers / Heart Damage Attorneys may be able to help you obtain compensation from the responsible parties. Contact Feldman & Pinto today to schedule a free evaluation of your catastrophic personal injury case.